<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01087957</url>
  </required_header>
  <id_info>
    <org_study_id>INSTRIDE</org_study_id>
    <nct_id>NCT01087957</nct_id>
  </id_info>
  <brief_title>WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients</brief_title>
  <official_title>Randomized Trial of the Innovative Neurotronics WalkAide Compared to Conventional Ankle-Foot Orthosis (AFO) in Stroke Patients (INSTRIDE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Innovative Neurotronics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Innovative Neurotronics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO)
      for patients with foot drop due to stroke, and to assess the functional improvement of
      ambulation and improved activities of daily living.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pivotal un-blinded, randomized, controlled trial with parallel group therapeutic
      intervention versus control of standard of care (AFO).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait Velocity</measure>
    <time_frame>6 months</time_frame>
    <description>Improved ambulation status, specific to increase in gait velocity (m/s)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke Impact Scale (SIS) Composite Score</measure>
    <time_frame>6 months</time_frame>
    <description>The SIS Composite score is equal to sum of scores for Mobility, ADL/IADL, and Social Participation domains. The questions for each domain are scored on a scale of 1-5, the higher the score the less the impact of Stroke on that domain question. The Mobility domain has 9 questions with scores ranging from 9 to 45. The ADL/IADL domain has 10 questions with scores ranging from 10-150- and the Social Participation domain has 8 question with a score of 8-40.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device Related Serious Adverse Events</measure>
    <time_frame>6 months</time_frame>
    <description>The device related serious adverse event (SAE) measure is a count of the incidences of adverse events defined as serious (Incapacitating with inability to do work or usual activities; signs and symptoms may be systemic in nature or require medical evaluation and/or treatment; requiring additional hospitalization or intensive care (prolonged hospitalization) and device related (any AE for which a causal relationship between the event and the presence of the device, or the performance of the device system, is at least a reasonable possibility (i.e., the relationship cannot be excluded).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Six Minute Walk Test</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Emory Functional Ambulation Profile Total Score</measure>
    <time_frame>6 months</time_frame>
    <description>The Modified Emory Functional Ambulation Profile (mEFAP) is composed of 5 subtasks: (1) 5 meter walk on a hard Floor, (2) 5 meter walk on a carpeted surface, (3) Timed Up &amp; Go (rising from a chair, a 3-meter walk, and return to a seated position), (4) Navigating a Standardized Obstacle Course, and (5) ascending and descending 4 Stairs. Each is a timed task with the score consisting of the number of seconds required to complete the task. Upon completion of the entire data collection session, a total mEFAP score is calculated by adding the score on each subtask.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Emory Functional Ambulation Profile Floor Time</measure>
    <time_frame>6 months</time_frame>
    <description>The Modified Emory Functional Ambulation Profile (mEFAP) Floor time sub-task is composed a timed 5 meter walk on a hard Floor. The score consists of the number of seconds required to complete the task. The Floor Time sub-task is added to the other 4 sub-tasks to make up the total mEFAP score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Emory Functional Ambulation Profile Carpet Time</measure>
    <time_frame>6 months</time_frame>
    <description>The Modified Emory Functional Ambulation Profile (mEFAP) Carpet time sub-task is composed of a 5 meter walk on a carpeted surface with the score consisting of the number of seconds required to complete the task. The score on the Carpet time sub-task is added to the other 4 sub-tasks to calculate the total mEFAP score .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Emory Functional Ambulation Profile Timed up and Go</measure>
    <time_frame>6 months</time_frame>
    <description>The Modified Emory Functional Ambulation Profile (mEFAP) Timed up and Go subtask is composed of rising from a chair, walking 3-meters, and returning to a seated position with the score consisting of the number of seconds required to complete the task. The Timed up and Go subtask is added to the other 4 sub-task scores to calculate the total mEFAP score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Emory Functional Ambulation Profile Obstacle Course</measure>
    <time_frame>6 months</time_frame>
    <description>The Modified Emory Functional Ambulation Profile (mEFAP) Obstacle course sub-task is composed navigating a Standardized Obstacle Course with the score consisting of the number of seconds required to complete the task. The obstacle course sub-task is added to the other 4 sub-tasks to calculate the total mEFAP score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Emory Functional Ambulation Profile Stair Time</measure>
    <time_frame>6 months</time_frame>
    <description>The Modified Emory Functional Ambulation Profile (mEFAP) Stair time sub-task is composed of ascending and descending 4 Stairs with the score consisting of the number of seconds required to complete the task. The Stair time sub-task score is added to the other 4 subtask scores to calculate the total mEFAP score .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berg Balance Scale</measure>
    <time_frame>6 months</time_frame>
    <description>The Berg Balance Assessment is a 14 item scale designed to measure balance in adults in a clinical setting. Each item is scored on a scale of 0-4 with a score of 0 indicating the most difficulty with the balance task. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">495</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Ankle-Foot Orthosis (AFO)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WalkAide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WalkAide</intervention_name>
    <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
    <arm_group_label>WalkAide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ankle-Foot Orthosis (AFO)</intervention_name>
    <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
    <arm_group_label>Ankle-Foot Orthosis (AFO)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient history of stroke (ischemic and/or hemorrhagic).

          -  Patient is at least 6 months post stroke.

          -  Patient has hemiplegia/hemiparesis.

          -  Patient has inadequate dorsiflexion during swing phase of gait, resulting in
             inadequate limb clearance.

          -  Patient is not currently using Functional Electrical Stimulation for the treatment of
             footdrop.

          -  Patient is a minimum of 30 days post inpatient or outpatient stroke, cardiac,
             pulmonary, or physical rehabilitation on the lower extremity.

          -  Patient is a minimum of 90 days post major orthopedic surgery (i.e. hip, knee, and/or
             ankle joint replacement).

          -  Patient is a minimum of 90 days post myocardial infarction.

          -  Patient is a minimum of 90 days post stenting procedure (i.e. peripheral, cardiac,
             carotid, and/or renal).

          -  Patient is a minimum of 6 months post CABG or cardiac valve procedure.

          -  Patient is able to walk at least 10 meters with or without an assist device (excluding
             an AFO or WalkAide device).

          -  Patient has an initial gait speed &gt; 0.0 m/s and &lt; 0.8 m/s.

          -  Patient has a positive response to peroneal nerve stimulation testing, resulting
             adequate dorsiflexion of the ankle.

          -  Patient has adequate cognitive function to permit reliable completion of evaluation
             instruments and to correctly use the therapeutic interventions as determined by a
             Mini-Mental Status test score &gt;17 within 30 days prior to enrollment.

          -  Patient has completed a full neurological assessment within 30 days prior to
             enrollment.

          -  Patient is eligible for Medicare or Medicare Choice/Advantage benefits at the time of
             enrollment

          -  Patient is able and willing to comply with study procedures, including follow-up
             requirements.

          -  Patient is able and willing to give written informed consent.

        Exclusion Criteria

          -  Patient is less than 6-months post stroke.

          -  Patient has inadequate cognitive function to permit reliable completion of evaluation
             instruments and to correctly use the therapeutic interventions as determined by a
             Mini-Mental Status test score &lt; 17 within 30 days prior to enrollment.

          -  Patient has ankle joint instability other than foot drop.

          -  Patient is less than 30 days post inpatient or outpatient: stroke, cardiac, pulmonary,
             or any type of physical rehabilitation on the lower extremity at time of enrollment.

          -  Patient has need for an AFO for stance control of the foot, ankle and/or knee.

          -  Patient has an initial gait speed of 0.8 m/s or greater classified as a full community
             walker (independent in all home and community activities).

          -  Patient is not able to safely clear toes in swing phase on the involved lower
             extremity, defined as &gt;-5° plantar flexion, with the device determined at fitting
             visit.

          -  Patient has been diagnosed with peripheral neuropathy and symptoms obstruct or limit
             ambulation or participation in study procedures.

          -  Patient has been diagnosed with significant peripheral vascular disease accompanied by
             lower extremity ulceration and/or disabling claudication.

          -  Patient has underlying condition(s) that would limit study participation such as
             severe hypertonicity resulting in the need for more involved orthotic strategies or
             excessive dysesthetic pain secondary to neurological involvement.

          -  Patient has moderate to very severe COPD, as defined by the Global Initiative for
             Chronic Obstructive Lung Disease (GOLD).

          -  Patient is NYHA Class III or IV.

          -  Patient has malignant skin lesion below the knee on the affected lower extremity.

          -  Patient has history of seizure disorder and on seizure medications.

          -  Patient has aphasia, defined as incapacity to verbalize commands.

          -  Patient has Beck Depression Index score of &gt; 29 indicating severe depression.

          -  Patient has a life expectancy less than 12 months.

          -  Patient has existing electrical stimulation devices (ICD, Pacemaker, Spinal
             Stimulation, TENS).

          -  Patient is less than 6 months free from Botulinum Toxin (Botox) injection in the lower
             extremity.

          -  Patient has baclofen pump with unstable dosing in the last 3 months.

          -  Patient is unable or unwilling to comply with study procedures, including follow-up
             requirements.

          -  Patient is participating in another clinical trial that, according to the Principal
             Investigator, is likely to affect study outcome or confound results.

          -  Patient is unable or unwilling to give written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois Bethoux, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Los Angeles VA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa Colina Centers for Rehabilitation</name>
      <address>
        <city>Pomona</city>
        <state>California</state>
        <zip>91769</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The San Francisco VA Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Halifax Hospital</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital NORI</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Institute of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marianjoy Rehabilitation</name>
      <address>
        <city>Wheaton</city>
        <state>Illinois</state>
        <zip>60187</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Hill Rehabilitation</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's of Michigan</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Twin-Cities</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madonna Rehabilitation Hospital</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kessler Foundation Research Center</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Healthcare</name>
      <address>
        <city>Johnson City</city>
        <state>New York</state>
        <zip>13790</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Shore Neurologic Associates</name>
      <address>
        <city>Patchogue</city>
        <state>New York</state>
        <zip>11772</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Research Inc./Helen Hayes Hospital</name>
      <address>
        <city>West Haverstraw</city>
        <state>New York</state>
        <zip>10993</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guilford Neurologic Associates</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FirstHealth of the Carolinas</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magee Rehabilitation Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. David's Rehabilitation Hospital</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Dallas VA</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic Research Foundation</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Bethoux F, Rogers HL, Nolan KJ, Abrams GM, Annaswamy TM, Brandstater M, Browne B, Burnfield JM, Feng W, Freed MJ, Geis C, Greenberg J, Gudesblatt M, Ikramuddin F, Jayaraman A, Kautz SA, Lutsep HL, Madhavan S, Meilahn J, Pease WS, Rao N, Seetharama S, Sethi P, Turk MA, Wallis RA, Kufta C. The effects of peroneal nerve functional electrical stimulation versus ankle-foot orthosis in patients with chronic stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2014 Sep;28(7):688-97. doi: 10.1177/1545968314521007. Epub 2014 Feb 13.</citation>
    <PMID>24526708</PMID>
  </results_reference>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2010</study_first_submitted>
  <study_first_submitted_qc>March 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2010</study_first_posted>
  <results_first_submitted>February 25, 2014</results_first_submitted>
  <results_first_submitted_qc>April 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 13, 2014</results_first_posted>
  <last_update_submitted>April 14, 2014</last_update_submitted>
  <last_update_submitted_qc>April 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ankle-Foot Orthosis (AFO)</title>
          <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="P2">
          <title>WalkAide</title>
          <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="253"/>
                <participants group_id="P2" count="242"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="212"/>
                <participants group_id="P2" count="187"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ankle-Foot Orthosis (AFO)</title>
          <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="B2">
          <title>WalkAide</title>
          <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="253"/>
            <count group_id="B2" value="242"/>
            <count group_id="B3" value="495"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.30" spread="12.01"/>
                    <measurement group_id="B2" value="63.87" spread="11.33"/>
                    <measurement group_id="B3" value="64.09" spread="11.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="157"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="187"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time Post Onset of Stroke</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.86" spread="6.64"/>
                    <measurement group_id="B2" value="6.90" spread="6.43"/>
                    <measurement group_id="B3" value="6.88" spread="6.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Initial Gait Speed</title>
          <units>meters/second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".487" spread=".21"/>
                    <measurement group_id="B2" value=".449" spread=".22"/>
                    <measurement group_id="B3" value=".47" spread=".21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mini Mental Status Exam</title>
          <description>The Mini Mental Status is a measure of cognitive function with a total possible score of 30 points. Any score greater than or equal to 27 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-24 points) cognitive impairment</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.49" spread="2.83"/>
                    <measurement group_id="B2" value="27.62" spread="2.44"/>
                    <measurement group_id="B3" value="27.54" spread="2.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beck Depression Inventory</title>
          <description>The Beck Depression inventory is a 21-question multiple-choice self-report inventory used for measuring the severity of depression. Each of the 21 questions is scored on a scale value of 0 to 3. Total score thresholds recommendations are as follows: 0–13: minimal depression; 14–19: mild depression; 20–28: moderate depression; and 29–63: severe depression. Higher total scores indicate more severe depressive symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.08" spread="6.58"/>
                    <measurement group_id="B2" value="7.98" spread="6.32"/>
                    <measurement group_id="B3" value="8.05" spread="6.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kilograms/meters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.21" spread="5.08"/>
                    <measurement group_id="B2" value="27.98" spread="4.93"/>
                    <measurement group_id="B3" value="28.61" spread="5.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gait Velocity</title>
        <description>Improved ambulation status, specific to increase in gait velocity (m/s)</description>
        <time_frame>6 months</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Gait Velocity</title>
          <description>Improved ambulation status, specific to increase in gait velocity (m/s)</description>
          <population>Intention to treat</population>
          <units>m/sec</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".682" spread=".020"/>
                    <measurement group_id="O2" value=".635" spread=".022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stroke Impact Scale (SIS) Composite Score</title>
        <description>The SIS Composite score is equal to sum of scores for Mobility, ADL/IADL, and Social Participation domains. The questions for each domain are scored on a scale of 1-5, the higher the score the less the impact of Stroke on that domain question. The Mobility domain has 9 questions with scores ranging from 9 to 45. The ADL/IADL domain has 10 questions with scores ranging from 10-150- and the Social Participation domain has 8 question with a score of 8-40.</description>
        <time_frame>6 months</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke Impact Scale (SIS) Composite Score</title>
          <description>The SIS Composite score is equal to sum of scores for Mobility, ADL/IADL, and Social Participation domains. The questions for each domain are scored on a scale of 1-5, the higher the score the less the impact of Stroke on that domain question. The Mobility domain has 9 questions with scores ranging from 9 to 45. The ADL/IADL domain has 10 questions with scores ranging from 10-150- and the Social Participation domain has 8 question with a score of 8-40.</description>
          <population>Intention to treat</population>
          <units>points</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172.7" spread="2.8"/>
                    <measurement group_id="O2" value="175.0" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Device Related Serious Adverse Events</title>
        <description>The device related serious adverse event (SAE) measure is a count of the incidences of adverse events defined as serious (Incapacitating with inability to do work or usual activities; signs and symptoms may be systemic in nature or require medical evaluation and/or treatment; requiring additional hospitalization or intensive care (prolonged hospitalization) and device related (any AE for which a causal relationship between the event and the presence of the device, or the performance of the device system, is at least a reasonable possibility (i.e., the relationship cannot be excluded).</description>
        <time_frame>6 months</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Device Related Serious Adverse Events</title>
          <description>The device related serious adverse event (SAE) measure is a count of the incidences of adverse events defined as serious (Incapacitating with inability to do work or usual activities; signs and symptoms may be systemic in nature or require medical evaluation and/or treatment; requiring additional hospitalization or intensive care (prolonged hospitalization) and device related (any AE for which a causal relationship between the event and the presence of the device, or the performance of the device system, is at least a reasonable possibility (i.e., the relationship cannot be excluded).</description>
          <population>Intention to treat</population>
          <units>number of device related SAEs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Six Minute Walk Test</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Six Minute Walk Test</title>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="218.6" spread="7.6"/>
                    <measurement group_id="O2" value="209.2" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Emory Functional Ambulation Profile Total Score</title>
        <description>The Modified Emory Functional Ambulation Profile (mEFAP) is composed of 5 subtasks: (1) 5 meter walk on a hard Floor, (2) 5 meter walk on a carpeted surface, (3) Timed Up &amp; Go (rising from a chair, a 3-meter walk, and return to a seated position), (4) Navigating a Standardized Obstacle Course, and (5) ascending and descending 4 Stairs. Each is a timed task with the score consisting of the number of seconds required to complete the task. Upon completion of the entire data collection session, a total mEFAP score is calculated by adding the score on each subtask.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Emory Functional Ambulation Profile Total Score</title>
          <description>The Modified Emory Functional Ambulation Profile (mEFAP) is composed of 5 subtasks: (1) 5 meter walk on a hard Floor, (2) 5 meter walk on a carpeted surface, (3) Timed Up &amp; Go (rising from a chair, a 3-meter walk, and return to a seated position), (4) Navigating a Standardized Obstacle Course, and (5) ascending and descending 4 Stairs. Each is a timed task with the score consisting of the number of seconds required to complete the task. Upon completion of the entire data collection session, a total mEFAP score is calculated by adding the score on each subtask.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="479.4" spread="38.3"/>
                    <measurement group_id="O2" value="498.0" spread="32.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Emory Functional Ambulation Profile Floor Time</title>
        <description>The Modified Emory Functional Ambulation Profile (mEFAP) Floor time sub-task is composed a timed 5 meter walk on a hard Floor. The score consists of the number of seconds required to complete the task. The Floor Time sub-task is added to the other 4 sub-tasks to make up the total mEFAP score.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Emory Functional Ambulation Profile Floor Time</title>
          <description>The Modified Emory Functional Ambulation Profile (mEFAP) Floor time sub-task is composed a timed 5 meter walk on a hard Floor. The score consists of the number of seconds required to complete the task. The Floor Time sub-task is added to the other 4 sub-tasks to make up the total mEFAP score.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.0" spread="8.0"/>
                    <measurement group_id="O2" value="52.5" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Emory Functional Ambulation Profile Carpet Time</title>
        <description>The Modified Emory Functional Ambulation Profile (mEFAP) Carpet time sub-task is composed of a 5 meter walk on a carpeted surface with the score consisting of the number of seconds required to complete the task. The score on the Carpet time sub-task is added to the other 4 sub-tasks to calculate the total mEFAP score .</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Emory Functional Ambulation Profile Carpet Time</title>
          <description>The Modified Emory Functional Ambulation Profile (mEFAP) Carpet time sub-task is composed of a 5 meter walk on a carpeted surface with the score consisting of the number of seconds required to complete the task. The score on the Carpet time sub-task is added to the other 4 sub-tasks to calculate the total mEFAP score .</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.1" spread="6.6"/>
                    <measurement group_id="O2" value="57.1" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Emory Functional Ambulation Profile Timed up and Go</title>
        <description>The Modified Emory Functional Ambulation Profile (mEFAP) Timed up and Go subtask is composed of rising from a chair, walking 3-meters, and returning to a seated position with the score consisting of the number of seconds required to complete the task. The Timed up and Go subtask is added to the other 4 sub-task scores to calculate the total mEFAP score.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Emory Functional Ambulation Profile Timed up and Go</title>
          <description>The Modified Emory Functional Ambulation Profile (mEFAP) Timed up and Go subtask is composed of rising from a chair, walking 3-meters, and returning to a seated position with the score consisting of the number of seconds required to complete the task. The Timed up and Go subtask is added to the other 4 sub-task scores to calculate the total mEFAP score.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131.0" spread="14.7"/>
                    <measurement group_id="O2" value="126.9" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Emory Functional Ambulation Profile Obstacle Course</title>
        <description>The Modified Emory Functional Ambulation Profile (mEFAP) Obstacle course sub-task is composed navigating a Standardized Obstacle Course with the score consisting of the number of seconds required to complete the task. The obstacle course sub-task is added to the other 4 sub-tasks to calculate the total mEFAP score.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Emory Functional Ambulation Profile Obstacle Course</title>
          <description>The Modified Emory Functional Ambulation Profile (mEFAP) Obstacle course sub-task is composed navigating a Standardized Obstacle Course with the score consisting of the number of seconds required to complete the task. The obstacle course sub-task is added to the other 4 sub-tasks to calculate the total mEFAP score.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169.8" spread="11.8"/>
                    <measurement group_id="O2" value="182.2" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Emory Functional Ambulation Profile Stair Time</title>
        <description>The Modified Emory Functional Ambulation Profile (mEFAP) Stair time sub-task is composed of ascending and descending 4 Stairs with the score consisting of the number of seconds required to complete the task. The Stair time sub-task score is added to the other 4 subtask scores to calculate the total mEFAP score .</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Emory Functional Ambulation Profile Stair Time</title>
          <description>The Modified Emory Functional Ambulation Profile (mEFAP) Stair time sub-task is composed of ascending and descending 4 Stairs with the score consisting of the number of seconds required to complete the task. The Stair time sub-task score is added to the other 4 subtask scores to calculate the total mEFAP score .</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.4" spread="5.3"/>
                    <measurement group_id="O2" value="79.3" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Berg Balance Scale</title>
        <description>The Berg Balance Assessment is a 14 item scale designed to measure balance in adults in a clinical setting. Each item is scored on a scale of 0-4 with a score of 0 indicating the most difficulty with the balance task. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ankle-Foot Orthosis (AFO)</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>WalkAide</title>
            <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Berg Balance Scale</title>
          <description>The Berg Balance Assessment is a 14 item scale designed to measure balance in adults in a clinical setting. Each item is scored on a scale of 0-4 with a score of 0 indicating the most difficulty with the balance task. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="253"/>
                <count group_id="O2" value="242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.7" spread="0.8"/>
                    <measurement group_id="O2" value="44.9" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ankle-Foot Orthosis (AFO)</title>
          <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
Ankle-Foot Orthosis (AFO): Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="E2">
          <title>WalkAide</title>
          <description>Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)
WalkAide: Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="253"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="253"/>
                <counts group_id="E2" events="9" subjects_affected="5" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitilized for abnormal Blood Sugar level</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitilization GI disorder</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="253"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="253"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="242"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="253"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="242"/>
              </event>
              <event>
                <sub_title>Back surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="253"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="253"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="242"/>
              </event>
              <event>
                <sub_title>TIA or CVA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="253"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="253"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="242"/>
              </event>
              <event>
                <sub_title>Renal failure/infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="253"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="146" subjects_at_risk="253"/>
                <counts group_id="E2" subjects_affected="162" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Falls</sub_title>
                <counts group_id="E1" events="173" subjects_affected="89" subjects_at_risk="253"/>
                <counts group_id="E2" events="173" subjects_affected="99" subjects_at_risk="242"/>
              </event>
              <event>
                <sub_title>Pain in back or Lower Extremity</sub_title>
                <counts group_id="E1" events="55" subjects_affected="30" subjects_at_risk="253"/>
                <counts group_id="E2" events="36" subjects_affected="26" subjects_at_risk="242"/>
              </event>
              <event>
                <sub_title>Muscle soreness</sub_title>
                <counts group_id="E1" events="15" subjects_affected="11" subjects_at_risk="253"/>
                <counts group_id="E2" events="15" subjects_affected="12" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Fatigue/Muscle weakness</sub_title>
                <counts group_id="E1" events="18" subjects_affected="9" subjects_at_risk="253"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin Irritation</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="253"/>
                <counts group_id="E2" events="34" subjects_affected="29" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Other medical conditions</sub_title>
                <description>Various events involving multiple systems</description>
                <counts group_id="E1" events="166" subjects_affected="65" subjects_at_risk="253"/>
                <counts group_id="E2" events="149" subjects_affected="70" subjects_at_risk="242"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>(b) Publication- Investigator and Institution agree not to publish the results of the Trial until after the conclusion of the Trial. Investigator agrees to submit to Sponsor copies of any proposed publication at least sixty (60) calendar days in advance of dissemination. Sponsor agrees to review and comment in a timely manner after receipt . All proprietary and/or confidential information of Sponsor must be removed from the Proposed Publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Helen Rogers PT, PhD</name_or_title>
      <organization>Innovative Neurotronics</organization>
      <phone>512-721-1922</phone>
      <email>hrogers@ininc.us</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

